Hudson Bay Capital Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.51M | Buy |
696,000
+104,580
| +18% | +$527K | 0.01% | 461 |
|
|
2025
Q1 | $3.83M | Sell |
591,420
-258,453
| -30% | -$1.67M | 0.01% | 403 |
|
|
2024
Q4 | $6.24M | Buy |
849,873
+321,631
| +61% | +$2.36M | 0.02% | 324 |
|
|
2024
Q3 | $3.96M | Buy |
528,242
+103,242
| +24% | +$773K | 0.02% | 339 |
|
|
2024
Q2 | $3.78M | Buy |
425,000
+140,000
| +49% | +$1.25M | 0.02% | 343 |
|
|
2024
Q1 | $2.89M | Sell |
285,000
-5,000
| -2% | -$50.7K | 0.02% | 340 |
|
|
2023
Q4 | $2.92M | Buy |
290,000
+82,500
| +40% | +$830K | 0.02% | 333 |
|
|
2023
Q3 | $1.94M | Buy |
207,500
+197,500
| +1,975% | +$1.85M | 0.02% | 417 |
|
|
2023
Q2 | $245K | Buy |
+10,000
| New | +$245K | ﹤0.01% | 580 |
|